A Pilot Trial Examining the Merits of Combining Amantadine and Repetitive Transcranial Magnetic Stimulation as an Intervention for Persons With Disordered Consciousness After TBI
Saved in:
Main Authors: | Sandra Kletzel, Theresa Bender Pape, Amy Herrold, Sherri Livengood, Ann Guernon, Todd Parrish, Trudy Mallinson, james higgins, Joshua Rosenow, Dulal Bhaumik |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f3f2dbe09e634bd38a609980b49ed29f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
by: Amy Herrold, et al.
Published: (2021) -
Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
by: Theresa Bender Pape
Published: (2021) -
Clinical and genetic investigation of amantadine-associated corneal edema
by: Hessen MM, et al.
Published: (2018) -
Precision targeting of brain networks in TBI
by: Shan Siddiqi
Published: (2021) -
Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells
by: Po-Yen Lee, et al.
Published: (2021)